Who to call at Nurix Therapeutics, and when
Fundz watches for the moments Nurix Therapeutics starts buying, and tells you who to reach.
- An alert the day Nurix Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nurix Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nurix Therapeutics. With Fundz connected, it knows.
Contract Type
partnership
BrisbaneOtherBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Nurix Therapeutics has announced a global collaboration with Roche to develop bexobrutideg, a novel therapy for B-cell malignancies. The partnership includes a robust clinical development plan with a total potential value of $2.3 billion, incorporating both hematology and plans for trials in neurology and immunology.
Quick answer
Nurix Therapeutics Partners with Roche to Develop Bexobrutideg for B-Cell Malignancies (June 8, 2026). Nurix Therapeutics is based in Brisbane, California, United States.
- What agreement did Nurix Therapeutics announce on June 8, 2026?
- Nurix Therapeutics has announced a global collaboration with Roche to develop bexobrutideg, a novel therapy for B-cell malignancies. The partnership includes a robust clinical development plan with a total potential value of $2.3 billion, incorporating both hematology and plans for trials in neurology and immunology.
- What does Nurix Therapeutics do?
- Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases.
- Where is Nurix Therapeutics based?
- Nurix Therapeutics is based in Brisbane, California, United States.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansNurix Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.